Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Tech Hammers U.S Markets

Published 04/10/2014, 04:32 PM
Updated 07/09/2023, 06:31 AM

Stocks resumed their April swoon Thursday, snapping two days of moderate gains with a broad-based sell-off that undercut the Nasdaq Index by more than 3%. Blue-chip equities as measured by the Dow Jones Industrials fared slightly better, falling about 1.6% as a group, but the broader S&P 500 was down over 2% by the close.

China's Data
Shares were under pressure throughout the session, turning lower soon after the opening bell following another big miss for a Chinese trade number reported overnight, casting new doubts on the pace of global growth.

China's export and import activity unexpectedly fell in March, with exports declining 6.6%, China's General Administration of Customs said, well under the 4% rise expected in the market consensus. The fall was even larger for imports, retreating 11.3% instead of the 2.4% gain experts had anticipated.

All 10 sectors in the S&P 500 finished in the red, led by declines by shares of healthcare, consumer discretionary and financial companies. Utility stock had the best day, declining less than 0.4%.

Commodities
Crude oil for May delivery settled 20 cents lower at $103.40 per barrel while May natural gas was up 7 cents to finish at $4.66 per 1 million BTU. June gold rose $15.10 to $1320.80 per ounce while May silver rose $0.33 to $20.10 per ounce. May copper added a penny to settle at $3.05 per pound.

Here's Where The U.S. Markets Stood At Day's End

  • Dow Jones Industrial Average down 181.18 (-1.72%) to 10,373.76
  • S&P 500 down 39.10 (-2.09%) to 1,833.08
  • Nasdaq Composite Index down 129.79 (-3.10%) to 4,054.11

GLOBAL SENTIMENT

  • Hang Seng Index up 1.51%
  • Shanghai China Composite Index up 1.38%
  • FTSE 100 Index up 0.10%

UPSIDE MOVERS

  • (+) RT, Non-GAAP Q3 net loss of $0.07 per share beats consensus by $0.01. Revenue falls 3.8% year over year to $295.6 mln, topping Street view by $10.8 mln. Expects same-store sales during Q4 to be up 1% to down 1% from year-ago levels.
  • (+) IGTE, Reports a 10% jump in revenue over year-ago levels to $302.2 mln, beats Street view by $1.2 mln. Adjusted profit of $0.45 tops analyst expectations by $0.04 per share.
  • (+) CLDN, Receives breakthrough therapy designation from FDA for its Mydicar drug candidate to treat potential heart failure.

DOWNSIDE MOVERS

  • (-) AGIO, Discloses plans to raise up to $86.3 million in a stock offering, including an overallotment option for underwriters. Proceeds will be used to fund trials of the company's blood-cancer treatments.
  • (-) IMPV, Reduces Q1 revenue guidance by $5 mln to a new range of $31.0 mln to $31.5 mln, trailing estimates by at least $5.1 mln. Boosts projected non-GAAP net loss by $0.07 to $0.40 to $0.44 per share, or at least $0.06 wider than estimates.
  • (-) BBBY, Q1 EPS outlook misses by at least $0.06; sees EPS growth in the mid-single digits compared with consensus expecting 10% growth. Matches analyst expectations with Q4 earnings of $1.60 per share on $3.2 bln in revenue.

After Hours Stock News From Midnight Trader.

Copyright © 2014 MT Newswires, a Division of MidnightTrader, Inc.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.